[Federal Register: December 1, 1998 (Volume 63, Number 230)]
[Rules and Regulations]
[Page 66018]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01de98-9]
[[Page 66018]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 558
New Animal Drugs for Use In Animal Feeds; Melengestrol Acetate
and Lasalocid; Technical Amendment
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule; technical amendment.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending and
clarifying the animal drug regulations concerning melengestrol acetate
(MGA) and the special considerations related to making type B and C
feeds and lasalocid type B liquid feed specifications used for making
lasalocid/MGA type C heifer feed.
EFFECTIVE DATE: December 1, 1998.
FOR FURTHER INFORMATION CONTACT: Jack Caldwell, Center For Veterinary
Medicine (HFV-126), Food and Drug Administration, 7500 Standish Pl.,
Rockville, MD 20855, 301-594-1638.
SUPPLEMENTARY INFORMATION: Pharmacia & Upjohn Co., 7000 Portage Rd.,
Kalamazoo, MI 49001-0199, is sponsor of NADA's 39-402 and 140-288 that
provide for combining separately approved melengestrol acetate (MGA)
(dry and liquid) and lasalocid (dry and liquid) type A medicated
articles to make lasalocid/MGA (dry and liquid) type B feeds. The type
B feeds are used to make dry type C feeds for heifers fed in
confinement for slaughter for increased rate of weight gain, improved
feed efficiency, and suppression of estrus (heat). The sponsor
requested that Sec. 558.342 (21 CFR 558.342) be amended to change the
special considerations in paragraph (c)(1) to read ``type B or C
medicated feeds'' and to change the limitations in paragraph (d)(3)(ii)
by adding the specification ``The liquid medicated feeds are required
to be manufactured in accordance with Sec. 558.311(d).'' FDA concurs
with the sponsor's request and extends the amendments to special
considerations to include all type B or C feeds for clarity as
originally intended. The regulations are amended in paragraph (c) of
Sec. 558.342 as requested.
    FDA has determined under 21 CFR 25.33(a)(1) that this action is of
a type that does not individually or cumulatively have a significant
effect on the human environment. Therefore, neither an environmental
assessment nor an environmental impact statement is required.
List of Subjects in 21 CFR Part 558
    Animal drugs, Animal feeds.
    Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center For Veterinary Medicine, 21 CFR part 558 is
amended as follows:
PART 558--NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
    1. The authority citation for 21 CFR part 558 continues to read as
follows:
    Authority: 21 U.S.C. 360b, 371.
Sec. 558.342   [Amended]
    2. Section 558.342 Melengestrol acetate is amended in paragraph (c)
after the phrase ``Type B'' each place it appears by adding the phrase
``or C'' and in paragraph (d)(3)(ii) by adding a sentence after the
first sentence to read ``The liquid medicated feeds are required to be
manufactured in accordance with Sec. 558.311(d).''.
    Dated: November 10, 1998.
Andrew J. Beaulieu,
Acting Director, Office of New Animal Drug Evaluation, Center for
Veterinary Medicine.
[FR Doc. 98-31573 Filed 11-30-98; 8:45 am]
BILLING CODE 4160-01-F